The clinical test to evaluate the effective and safety dosage of dantrolene for the treatment of ventricular tachycardia in patients with heart disease
Not Applicable
Recruiting
- Conditions
- Ventricular tachycardia (CPVT, ARVC, Heart failure)
- Registration Number
- JPRN-UMIN000004346
- Lead Sponsor
- Department of Medicine and Clinical Science Yamaguchi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
COPD muscle dystrophy patients with hepatic disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to investigate the effective and safety dosage of dantrolene for the treatment of ventricular tachycardia in patients with heart disease
- Secondary Outcome Measures
Name Time Method